Epigenomics AG (FRA:ECX)
Germany · Delayed Price · Currency is EUR 0.9200
+0.4800 (52.17%)
Apr 21, 2026, 1:14 PM CET
Epigenomics AG Market Cap
Epigenomics AG has a market cap or net worth of €806.82 thousand as of April 21, 2026. Its market cap has decreased by -12.20% in one year.
Market Cap
806.82K
Enterprise Value
11.77M
Revenue
24.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.92
Market Cap Chart
Since September 22, 2014, Epigenomics AG's market cap has decreased from 52.02M to 806.82K, a decrease of -98.45%. That is a compound annual growth rate of -30.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 806.82K | 2.23% |
| Dec 30, 2025 | 789.25K | -19.48% |
| Dec 30, 2024 | 980.17K | -38.24% |
| Dec 29, 2023 | 1.59M | -76.50% |
| Dec 30, 2022 | 6.75M | -17.48% |
| Dec 30, 2021 | 8.18M | -57.46% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 51.52B |
| Siemens Healthineers AG | 43.41B |
| Bayer Aktiengesellschaft | 40.38B |
| Fresenius SE & Co. KGaA | 25.13B |
| Maternus-Kliniken Aktiengesellschaft | 24.12M |
| aap Implantate AG | 23.65M |
| NanoRepro AG | 18.73M |
| Biofrontera AG | 15.56M |